ZA99918B - Pharmaceutical formulation. - Google Patents

Pharmaceutical formulation.

Info

Publication number
ZA99918B
ZA99918B ZA9900918A ZA99918A ZA99918B ZA 99918 B ZA99918 B ZA 99918B ZA 9900918 A ZA9900918 A ZA 9900918A ZA 99918 A ZA99918 A ZA 99918A ZA 99918 B ZA99918 B ZA 99918B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
ZA9900918A
Other languages
English (en)
Inventor
Ann Margaret Dyer
Alan Smith
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA99918B publication Critical patent/ZA99918B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9900918A 1998-02-07 1999-02-05 Pharmaceutical formulation. ZA99918B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ZA99918B true ZA99918B (en) 2000-08-07

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900918A ZA99918B (en) 1998-02-07 1999-02-05 Pharmaceutical formulation.

Country Status (24)

Country Link
US (1) US6239165B1 (cs)
EP (1) EP1054666B1 (cs)
JP (1) JP2002502818A (cs)
KR (1) KR20010040717A (cs)
AR (1) AR018062A1 (cs)
AT (1) ATE227988T1 (cs)
AU (1) AU2720099A (cs)
BG (1) BG104682A (cs)
BR (1) BR9907644A (cs)
CA (1) CA2320475A1 (cs)
CO (1) CO4970815A1 (cs)
CZ (1) CZ291975B6 (cs)
DE (1) DE69904021T2 (cs)
DK (1) DK1054666T3 (cs)
ES (1) ES2188135T3 (cs)
GB (1) GB9802617D0 (cs)
HR (1) HRP20000579A2 (cs)
HU (1) HUP0100769A3 (cs)
PL (1) PL342213A1 (cs)
PT (1) PT1054666E (cs)
SK (1) SK11472000A3 (cs)
TR (1) TR200002288T2 (cs)
WO (1) WO1999039709A1 (cs)
ZA (1) ZA99918B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247067A (en) * 1968-02-16 1971-09-22 Fujisawa Pharmaceutical Co Tricyclic enol ether compounds and the preparation thereof
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) * 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
EP0733368A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Granule fomulation for olanzapine
GB9526264D0 (en) * 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
GB9802617D0 (en) 1998-04-01
EP1054666B1 (en) 2002-11-20
EP1054666A1 (en) 2000-11-29
ATE227988T1 (de) 2002-12-15
BR9907644A (pt) 2000-11-14
CA2320475A1 (en) 1999-08-12
BG104682A (bg) 2001-05-31
AR018062A1 (es) 2001-10-31
ES2188135T3 (es) 2003-06-16
HK1033088A1 (en) 2001-08-17
TR200002288T2 (tr) 2000-12-21
US6239165B1 (en) 2001-05-29
HUP0100769A2 (hu) 2001-12-28
AU2720099A (en) 1999-08-23
HUP0100769A3 (en) 2002-04-29
SK11472000A3 (sk) 2001-08-06
CZ20002846A3 (cs) 2000-12-13
KR20010040717A (ko) 2001-05-15
HRP20000579A2 (en) 2001-04-30
DE69904021D1 (de) 2003-01-02
CO4970815A1 (es) 2000-11-07
PL342213A1 (en) 2001-05-21
JP2002502818A (ja) 2002-01-29
PT1054666E (pt) 2003-03-31
DE69904021T2 (de) 2003-04-30
CZ291975B6 (cs) 2003-06-18
DK1054666T3 (da) 2003-03-17
WO1999039709A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
ZA993338B (en) Pharmaceutical formulations.
MXPA01010676A (es) Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
ZA200200743B (en) Preserved pharmaceutical formulations.
ZA974735B (en) Pharmaceutical compositions.
ZA981029B (en) Pharmaceutical agents.
ZA200104280B (en) Pharmaceutical combination preparations.
ZA200005510B (en) Pharmaceutical composition.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA200000857B (en) Pharmaceutical composition.
ZA977104B (en) Pharmaceutical compositions.
ZA989680B (en) Pharmaceutical composition.
ZA987392B (en) Pharmaceutical composition.
GB9818927D0 (en) Pharmaceutical formulation
ZA200203311B (en) Pharmaceutical carrier formulation.
ZA972602B (en) Pharmaceutical compositions.
ZA200110454B (en) Pharmaceutical complex.
ZA99890B (en) Pharmaceutical compositions.
GB9822333D0 (en) Pharmaceutical formulation
GB9817470D0 (en) Pharmaceutical formulation
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
ZA994697B (en) Pharmaceutical formulation.
ZA99918B (en) Pharmaceutical formulation.
ZA997202B (en) Pharmaceutical composition.
ZA997229B (en) Medicinal formulation.
GB9828707D0 (en) Pharmaceutical uses